Merz signs Gwyneth Paltrow as face of Xeomin toxin

Aesthetics company Merz Aesthetics has announced a partnership with actor and entrepreneur Gwyneth Paltrow as the new face of its Xeomin (incobotulinumtoxinA) toxin product.

Xeomin is an FDA-approved anti-wrinkle injection for frown lines that is “uniquely purified to remove unnecessary proteins”. 

“Sharing pure and proven products with other women in a core part of my philosophy, which is why I’m so excited to work with Merz on this campaign for Xeomin,” said Paltrow.

“I want women to realise how pure products changed my life, and that they have choices when it comes to anti-wrinkle injections for frown lines.”

Last year, Merz restructured the business to form the dedicated Merz Aesthetics division.